EVS Glaucoma Therapeutics (EGT), a Herndon-based spinout of Euclid Vision Systems that will develop a sustained delivery system for glaucoma medication. EGT will develop an implantable, bio-degradable, collagen-based drug delivery system for Latanoprost, the leading prescribed glaucoma medication.
